Related Experiment Video
Updated: May 25, 2026
07:03
Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
Published on: March 18, 2019
Electrocardiographic toxicity in the guinea pig
1Porsolt and Partners Pharmacology, Boulogne Billancourt, France.
Current Protocols in Pharmacology
|February 2, 2012
Summary
Assessing new drug candidates for potential cardiac rhythm abnormalities is crucial. This study introduces a protocol using anesthetized guinea pigs to detect electrocardiographic toxicity early in drug development.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Cardiac rhythm abnormalities are common clinical cardiology issues.
- Certain drug classes, including antidepressants and antiarrhythmics, can cause electrocardiographic toxicity.
- Early assessment of new compounds for cardiac effects is vital during drug development.
Purpose of the Study:
- To present a reliable protocol for detecting electrocardiographic toxicity of novel compounds.
- To provide an early-phase drug development assessment tool for cardiac safety.
Main Methods:
- Utilizing an anesthetized guinea pig model.
- Implementing a protocol to monitor and detect electrocardiographic changes indicative of toxicity.
Main Results:
- The presented protocol effectively detects electrocardiographic toxicity in test compounds.
- The guinea pig model serves as a viable platform for preclinical cardiac safety evaluation.
Conclusions:
- The developed protocol is valuable for early identification of potential cardiac risks associated with new chemical entities.
- This method aids in ensuring the safety of pharmaceutical compounds before human trials.
